A new treatment for smallpox has been registered in Russia, attracting the interest of the scientific community. This drug could bolster efforts to combat this disease, which has been eradicated but remains a potential threat. Details on its efficacy and mode of action are awaited, as researchers hope for a significant breakthrough in the field of antivirals.